Capital Insight Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.83M | Sell |
14,485
-1,744
| -11% | -$221K | 0.32% | 72 |
|
|
2025
Q1 | $2.08M | Buy |
16,229
+362
| +2% | +$46.3K | 0.36% | 71 |
|
|
2024
Q4 | $2.1M | Buy |
15,867
+1,436
| +10% | +$190K | 0.36% | 74 |
|
|
2024
Q3 | $2.1M | Buy |
14,431
+739
| +5% | +$108K | 0.37% | 73 |
|
|
2024
Q2 | $1.88M | Buy |
13,692
+766
| +6% | +$105K | 0.35% | 74 |
|
|
2024
Q1 | $1.77M | Buy |
12,926
+653
| +5% | +$89.6K | 0.33% | 74 |
|
|
2023
Q4 | $1.67M | Buy |
12,273
+269
| +2% | +$36.5K | 0.34% | 75 |
|
|
2023
Q3 | $1.47M | Buy |
12,004
+1,069
| +10% | +$131K | 0.33% | 76 |
|
|
2023
Q2 | $1.39M | Buy |
10,935
+2,157
| +25% | +$274K | 0.31% | 78 |
|
|
2023
Q1 | $1.13M | Buy |
8,778
+3,456
| +65% | +$446K | 0.27% | 90 |
|
|
2022
Q4 | $699K | Buy |
+5,322
| New | +$699K | 0.18% | 99 |
|